• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

2-Azetidinones as inhibitors of cholesterol absorption.

作者信息

Burnett D A, Caplen M A, Davis H R, Burrier R E, Clader J W

机构信息

Schering-Plough Research Institute, Kenilworth, New Jersey 07033-0539.

出版信息

J Med Chem. 1994 Jun 10;37(12):1733-6. doi: 10.1021/jm00038a001.

DOI:10.1021/jm00038a001
PMID:8021912
Abstract
摘要

相似文献

1
2-Azetidinones as inhibitors of cholesterol absorption.
J Med Chem. 1994 Jun 10;37(12):1733-6. doi: 10.1021/jm00038a001.
2
Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461.新型胆固醇吸收抑制剂SCH 48461的降胆固醇活性
Atherosclerosis. 1995 May;115(1):45-63. doi: 10.1016/0021-9150(94)05499-9.
3
Carboxy-substituted 2-azetidinones as cholesterol absorption inhibitors.作为胆固醇吸收抑制剂的羧基取代的2-氮杂环丁酮
Bioorg Med Chem Lett. 1998 Feb 3;8(3):319-22. doi: 10.1016/s0960-894x(98)00009-2.
4
Synthesis of C3 heteroatom-substituted azetidinones that display potent cholesterol absorption inhibitory activity.具有强效胆固醇吸收抑制活性的含C3杂原子取代氮杂环丁烷-2-酮的合成。
J Med Chem. 1998 Feb 26;41(5):752-9. doi: 10.1021/jm970676d.
5
2-Azetidinone cholesterol absorption inhibitors: structure-activity relationships on the heterocyclic nucleus.
J Med Chem. 1996 Sep 13;39(19):3684-93. doi: 10.1021/jm960405n.
6
Hypocholesterolemic activity of some novel azetidin-2-ones in diet and diabetes induced hypercholesterolemia in rats.某些新型氮杂环丁烷-2-酮对饮食和糖尿病诱导的大鼠高胆固醇血症的降胆固醇活性。
Pharmazie. 2005 May;60(5):369-74.
7
Acyl CoA:cholesterol acyltransferase (ACAT) inhibitors: synthesis and structure-activity relationship studies of a new series of trisubstituted imidazoles.酰基辅酶A：胆固醇酰基转移酶（ACAT）抑制剂：一系列新型三取代咪唑的合成及构效关系研究
J Med Chem. 1994 Oct 14;37(21):3511-22. doi: 10.1021/jm00047a009.
8
Synthesis and hypocholesterolemic activity of 6,7-dihydro-4H-pyrazolo[1,5-a]pyrrolo[3,4-d]pyrimidine-5,8-diones, novel inhibitors of acylCoA:cholesterol O-acyltransferase.新型酰基辅酶A：胆固醇O-酰基转移酶抑制剂6,7-二氢-4H-吡唑并[1,5-a]吡咯并[3,4-d]嘧啶-5,8-二酮的合成及降胆固醇活性
J Med Chem. 1991 May;34(5):1721-7. doi: 10.1021/jm00109a028.
9
Synthesis of iodinated biochemical tools related to the 2-azetidinone class of cholesterol absorption inhibitors.与2-氮杂环丁酮类胆固醇吸收抑制剂相关的碘化生化工具的合成。
Bioorg Med Chem Lett. 2002 Feb 11;12(3):311-4. doi: 10.1016/s0960-894x(01)00750-8.
10
Multiple mechanisms of hypocholesterolemic action of pactimibe, a novel acyl-coenzyme A:cholesterol acyltransferase inhibitor.新型酰基辅酶A：胆固醇酰基转移酶抑制剂帕替米贝降胆固醇作用的多种机制
Eur J Pharmacol. 2006 Aug 14;543(1-3):123-32. doi: 10.1016/j.ejphar.2006.05.036. Epub 2006 Jun 2.

引用本文的文献

1
Machine and deep learning models for predicting high pressure density of heterocyclic thiophenic compounds based on critical properties.基于临界性质预测杂环噻吩类化合物高压密度的机器学习和深度学习模型。
Sci Rep. 2025 Jul 15;15(1):25465. doi: 10.1038/s41598-025-09600-z.
2
Variable-Sized bis(4-spiro-fused-β-lactam)-Based Unsaturated Macrocycles: Synthesis and Characterization.基于可变大小双（4-螺环稠合-β-内酰胺）的不饱和大环化合物：合成与表征
ACS Omega. 2022 Oct 4;7(41):36795-36803. doi: 10.1021/acsomega.2c05212. eCollection 2022 Oct 18.
3
Alphataxin, an Orally Available Small Molecule, Decreases LDL Levels in Mice as a Surrogate for the LDL-Lowering Activity of Alpha-1 Antitrypsin in Humans.
α-毒素，一种口服可用的小分子，可降低小鼠体内的低密度脂蛋白水平，作为α-1抗胰蛋白酶在人体内降低低密度脂蛋白活性的替代指标。
Front Pharmacol. 2021 Jun 9;12:695971. doi: 10.3389/fphar.2021.695971. eCollection 2021.
4
Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition.依折麦布通过 AMP 激活蛋白激酶-TFEB 介导的自噬激活和 NLRP3 炎性体抑制改善脂肪性肝炎。
Autophagy. 2017 Oct 3;13(10):1767-1781. doi: 10.1080/15548627.2017.1356977. Epub 2017 Sep 21.
5
Fungal biotransformation of ezetimibe.
Biotechnol Biotechnol Equip. 2014 Sep 3;28(5):934-940. doi: 10.1080/13102818.2014.966948. Epub 2014 Nov 17.
6
Fomiroid A, a novel compound from the mushroom Fomitopsis nigra, inhibits NPC1L1-mediated cholesterol uptake via a mode of action distinct from that of ezetimibe.木耳素A是一种从黑拟层孔菌中提取的新型化合物，它通过一种不同于依泽替米贝的作用方式抑制NPC1L1介导的胆固醇摄取。
PLoS One. 2014 Dec 31;9(12):e116162. doi: 10.1371/journal.pone.0116162. eCollection 2014.
7
Novel amino-β-lactam derivatives as potent cholesterol absorption inhibitors.新型氨基-β-内酰胺衍生物作为有效的胆固醇吸收抑制剂。
Eur J Med Chem. 2014 Nov 24;87:722-34. doi: 10.1016/j.ejmech.2014.10.014. Epub 2014 Oct 7.
8
Modern Multicomponent Reactions for better Drug Syntheses**.用于更好药物合成的现代多组分反应**
Org Chem Front. 2014 Sep 1;1(7):834-837. doi: 10.1039/C4QO00088A.
9
The discovery of first-in-class drugs: origins and evolution.首创药物的发现：起源与演变。
Nat Rev Drug Discov. 2014 Aug;13(8):577-87. doi: 10.1038/nrd4336. Epub 2014 Jul 18.
10
Ezetimibe: its novel effects on the prevention and the treatment of cholesterol gallstones and nonalcoholic Fatty liver disease.依折麦布：其在预防和治疗胆固醇性胆结石及非酒精性脂肪性肝病方面的新作用
J Lipids. 2012;2012:302847. doi: 10.1155/2012/302847. Epub 2011 Nov 3.